CJC-1295 with DAC: Long-Acting GHRH Analog Research Overview

Research overview of CJC-1295 with Drug Affinity Complex (DAC) — how the DAC albumin-binding technology extends half-life from 30 minutes to 6-8 days, bleed GH vs pulsatile comparison, typical research doses (1-2mg weekly), and comparison with MOD GRF 1-29 (CJC-1295 without DAC).

TL;DR

• CJC-1295 with DAC: albumin-binding modification extends half-life to 6-8 days → once/twice weekly dosing
• Produces "GH bleed" — tonic GH/IGF-1 elevation vs. pulsatile GH from shorter-acting GHRH analogs
• Typical research dose: 1-2mg subcutaneously once or twice weekly
• CJC-1295 without DAC = MOD GRF 1-29 — same peptide backbone, different pharmacokinetics
• Pulsatile (MOD GRF daily) is considered more physiological; DAC version is more convenient

Disclaimer: For educational and research purposes only — not medical advice.

Growth hormone-releasing hormone (GHRH) is a 44-amino acid hypothalamic peptide that stimulates pituitary GH secretion. Native GHRH has a half-life of only 2-7 minutes in plasma due to rapid enzymatic degradation. CJC-1295 is a modified GHRH analog engineered for improved stability — and the DAC version takes this further by enabling albumin binding for dramatically extended duration of action.

The Albumin-Binding Technology

The Drug Affinity Complex (DAC) consists of a maleimidopropionic acid (MPA) linker attached to the peptide. This linker covalently bonds to a cysteine-34 on serum albumin after injection. Key properties:

• Albumin half-life: ~19 days — among the longest half-lives of plasma proteins
• CJC-1295 + DAC half-life: 6-8 days (limited by peptide-albumin bond stability)
• Dosing frequency: Once or twice per week
• Result: Sustained GHRH receptor stimulation between doses

This technology was originally developed to create long-acting analogs of therapeutic peptides for pharmaceutical applications — the same albumin-binding approach used in modified GLP-1 agonists.

GH Bleed: The Pharmacokinetic Trade-Off

The key research debate around CJC-1295 with DAC concerns the "GH bleed" phenomenon:

With MOD GRF + GHRP (pulsatile approach):

• Large GH spike (5-20 ng/mL) lasting 2-3 hours
• Returns to baseline between pulses
• Mirrors natural GH secretion physiology
• GH receptor sees alternating stimulation and rest

With CJC-1295 DAC (tonic approach):

• Low-level, continuous GH elevation throughout the week
• IGF-1 moderately elevated across the entire week
• No meaningful GH pulses or valleys
• GH receptor exposed to continuous stimulation → potential downregulation

This tonic pattern is functionally similar to exogenous GH administration in terms of receptor kinetics — unlike the pulsatile approach that many researchers consider more aligned with healthy GH physiology.

Research Dosing

Typical IGF-1 elevation: CJC-1295 DAC at 1-2mg/week raises IGF-1 by 100-200% in clinical research (from baseline of ~100-150 ng/mL to 200-350 ng/mL in some studies).

CJC-1295 DAC vs. MOD GRF 1-29 Comparison

Combination Protocols

CJC-1295 DAC alone: Some researchers use DAC-CJC-1295 as a standalone compound, taking advantage of the convenience of once-weekly dosing without daily GHRP injections. The GHRH alone still elevates GH and IGF-1 meaningfully.

CJC-1295 DAC + GHRP: Adding a GHRP (Ipamorelin, GHRP-2) on the days of CJC-1295 DAC injection amplifies the GH pulse through synergistic GHRH + GHRP receptor co-activation. Daily GHRP can be continued throughout the week for additional pulsatile GH support on top of the GHRH tonic background.

Frequently Asked Questions

Q: Is CJC-1295 with DAC suppressive to natural GH production? A: CJC-1295 with DAC stimulates pituitary GH release but does not suppress the hypothalamic-pituitary axis in the way exogenous GH does. The pituitary retains its ability to produce and secrete GH. However, chronic, continuous GHRH receptor stimulation may reduce receptor sensitivity over time — a potential rationale for cycling (e.g., 8-12 weeks on, 4-6 weeks off).

Q: How should reconstitution and storage be handled for CJC-1295 DAC? A: CJC-1295 DAC lyophilized powder is reconstituted with bacteriostatic water (BAC water). Standard reconstitution yields concentrations of 1-2mg/mL. Reconstituted peptide should be stored refrigerated (2-8°C) and is typically stable for 30-60 days. Due to the large DAC molecule, CJC-1295 with DAC may have slightly different solubility characteristics than smaller peptides — gentle swirling (not vigorous shaking) is recommended.

Use the Reconstitution Calculator → /calculators/reconstitution

For educational and research purposes only. Not medical advice.

Disclaimer: For educational and research purposes only. Nothing in this article constitutes medical advice, diagnosis, or treatment recommendation. All compounds discussed are research chemicals or investigational compounds unless explicitly noted otherwise. Consult a qualified healthcare professional before making any health-related decisions. Researchers must comply with all applicable laws and regulations in their jurisdiction.

Frequently Asked Questions